Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Denali Therapeutics
201 Gateway Blvd
San Francisco, CA 94080
Phone: 650-866-8555

Denali Therapeutics is a privately held biotechnology company focused on the discovery and development of therapies for patients with neurodegenerative disease, including Alzheimer's disease, Parkinson's disease, ALS and others. Located in South San Francisco, Denali was founded by Drs. Marc Tessier-Lavigne, Ryan Watts, Alex Schuth and investors who share the vision that recent scientific insights in genetics, biology and translational medicine offer an unprecedented opportunity to discover and develop effective medicines for neurodegenerative disease.

Key Contact
Name
Ryan Watts
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
08/26/16 $130,000,000 Series B Alaska Permanent Fund
ARCH Venture Partners
Baillie Gifford
Fidelity Biosciences
Flagship Ventures
undisclosed